- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Gw Pharmaceuticals Share News (GWP)
Share News for Gw Pharmaceuticals (GWP)
| Share Price: 49.375 | Bid: 49.00 | Ask: 49.75 | Change: 0.00 (0.00%) |  | ||||||
| ||||||||||
Thomson Financial Europe AM at a glance share guide: Stocks lower, oil rises
LONDON (Thomson Financial) - US SUMMARY: Stocks snap 3-day gains; crude rises above 69 usd Index Change Pct chang[19 Jun '07]
GW Pharma starts Phase I trial of obesity treatment product THCV
LONDON (Thomson Financial) - GW Pharmaceuticals PLC said it has started a Phase I study of its delta-9-tetrahydrocannabivarin (THCV) product for[4 Jun '07]
GW, Otsuka get US antitrust clearance for Sativex marketing deal
LONDON (AFX) - GW Pharmaceuticals PLC and Otsuka Pharmaceutical said US antitrust authorities have approved the exclusive licensing and developm[22 Mar '07]
GW Pharmaceuticals appoints James Noble as deputy chairman
LONDON (AFX) - GW Pharmaceuticals PLC said it has appointed senior independent director James Noble as its first deputy chairman, as it conclude[15 Mar '07]
UK smallcap opening - GW Pharmaceuticals better on Sativex update
LONDON (AFX) - Modest progress was registered in GW Pharmaceuticals, 3-1/2 pence better at 92-1/2, following news that a study shows its cannabi[28 Feb '07]
GW Pharma study shows pain drug Sativex reduces spasms, stiffness in MS patients
LONDON (AFX) - GW Pharmaceuticals PLC said a study shows that its cannabis-based pain drug Sativex significantly reduces spasms and stiffness in[28 Feb '07]
GW Pharmaceuticals teams up with Otsuka for US licensing of Sativex
LONDON (AFX) - GW Pharmaceuticals PLC said it has entered into a strategic alliance with Otsuka Pharmaceutical Co Ltd for the US licensing of GW[14 Feb '07]
GW Pharmaceuticals says talks on US licensing for Sativex 'progressing' well
LONDON (AFX) - GW Pharmaceuticals PLC said the talks with potential US licensing partners for its lead cannabis-based pain drug Sativex are 'pro[13 Feb '07]
